ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,800,000 | +65.1% | 705,608 | +100.0% | 0.15% | -12.1% |
| Q3 2021 | $11,992,000 | -58.4% | 352,804 | -50.0% | 0.17% | -7.0% |
| Q2 2021 | $28,832,000 | +103.0% | 705,608 | +100.0% | 0.19% | +3.9% |
| Q1 2021 | $14,204,000 | -73.5% | 352,804 | -61.0% | 0.18% | -68.6% |
| Q4 2020 | $53,504,000 | +32.6% | 904,854 | +9.0% | 0.57% | -2.5% |
| Q3 2020 | $40,363,000 | +73.8% | 830,000 | +72.9% | 0.59% | +56.6% |
| Q2 2020 | $23,222,000 | +73.0% | 480,000 | -3.0% | 0.38% | +7.4% |
| Q1 2020 | $13,424,000 | +47.1% | 495,000 | +62.3% | 0.35% | +93.4% |
| Q4 2019 | $9,126,000 | +0.1% | 305,000 | +3.4% | 0.18% | -26.4% |
| Q3 2019 | $9,116,000 | -33.8% | 295,000 | +3.5% | 0.25% | -22.2% |
| Q2 2019 | $13,766,000 | – | 285,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |